Transcriptional alteration in the treatment of MDA-MB-231 cells using BITC and/or ZA
We report differential gene expression changes by benzyl isothiocyanate (BITC) and/or zoledronic acid (ZA) in MDA-MB-231 human breast cancer cell line Overall design: Examinine the transcriptome regulated by BITC and/or ZA in the MDA-MB-231 human breast cancer cell line